^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

EGFR806-specific CAR T-cell therapy

i
Company:
Cellevolve Bio, Seattle Children's Hospital, Seattle Children’s Therapeutics
Drug class:
EGFR-targeted CAR-T immunotherapy